Cross-sectional seroprevalence surveys of SARS-CoV-2 antibodies in children in Germany, June 2020 to May 20212020년 6월부터 2021년 5월까지 독일 어린이의 SARS-CoV-2 항체에 대한 단면 혈청 유병률 조사Article Published on 2022-06-062022-09-12 Journal: Nature Communications [Category] COVID19(2023년), MERS, SARS, 진단, 치료기술, [키워드] 95% CI anti-SARS-CoV-2 IgG Asymptomatic children cross-sectional Germany hospital Infection infections outcome parent Rate recalled recruited required risk SARS-CoV-2 antibody SARS-COV-2 infection SARS-CoV-2 infections serologic testing seropositive Seropositivity seroprevalence survey Spread [DOI] 10.1038/s41467-022-30482-6 PMC 바로가기 [Article Type] Article
Seropositivity of main vector-borne pathogens in dogs across EuropeArticle Published on 2022-06-062023-06-22 Journal: Parasites & Vectors [Category] 조류인플루엔자, [키워드] Anaplasma Borrelia burgdorferi Dirofilaria immitis dogs Ehrlichia Europe Leishmania Seropositivity [DOI] 10.1186/s13071-022-05316-5 PMC 바로가기
Seroprevalence of SARS-CoV-2 IgG antibody among healthy blood donors: a single centre study건강한 헌혈자 중 SARS-CoV-2 IgG 항체의 혈청 유병률: 단일 센터 연구Article Published on 2022-06-012022-09-11 Journal: Transfusion and apheresis science : official journ [Category] COVID19(2023년), MERS, SARS, 진단, 치료기술, [키워드] acute respiratory syndrome addition age Analysis antibody association Blood blood donor Blood donors Blood Group causative agent chemiluminescence Community Corona virus COVID-19 cross-sectional cross-sectional study detect Donor donors enrolled global pandemic healthy healthy blood donor healthy blood donors IgG antibody indication Infection majority Off Prevalence reactive respiratory SARS- CoV-2 SARS-CoV SARS-CoV-2 antibody SARS-CoV-2 IgG SARS-CoV-2 IgG antibody SARS-COV-2 infection screened seronegative seropositive Seropositivity Seroprevalence serum sample serum samples Severe acute respiratory syndrome Severe Acute Respiratory Syndrome Corona Virus signal statistically significant transmitted virus was used Whole blood [DOI] 10.1016/j.transci.2021.103338 PMC 바로가기 [Article Type] Article
Anti-SARS CoV-2 IgG in COVID-19 Patients with Hematological Diseases: A Single-center, Retrospective Study in Japan혈액 질환이 있는 COVID-19 환자의 Anti-SARS CoV-2 IgG: 일본의 단일 센터, 후향적 연구Article Published on 2022-06-012022-09-11 Journal: Internal medicine (Tokyo, Japan) [Category] COVID19(2023년), MERS, SARS, 진단, 치료기술, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 adult COVID-19 patient anti-SARS-CoV-2 anti-SARS-CoV-2 antibodies anti-SARS-CoV-2 antibody antibody caused coronavirus coronavirus disease COVID-19 COVID-19 patient COVID-19 patients COVID-19 severity develop disease Diseases disorders enrolled explain hematological IgG IgG antibodies IgG antibody Immunoglobulin Immunoglobulin G information Japan less objective outcome Patient Receptor-binding domain reported respiratory Result Retrospective study rituximab SARS-CoV-2 SARS-CoV-2 IgG SARS-CoV-2 IgG antibodies Seronegativity Seropositivity severe acute respiratory syndrome Coronavirus significantly single-center Spike protein Spread the receptor-binding domain the spike protein [DOI] 10.2169/internalmedicine.9209-21 PMC 바로가기 [Article Type] Article
Efficacy of antibody response following the vaccination of SARS-CoV-2 infected and noninfected healthcare workers by two-dose inactive vaccine against COVID-19COVID-19에 대한 2회 접종 불활성 백신에 의한 SARS-CoV-2 감염 및 비감염 의료 종사자의 백신 접종 후 항체 반응의 효능Article Published on 2022-06-012022-09-11 Journal: Journal of medical virology [Category] COVID19(2023년), MERS, SARS, 진단, 치료기술, [키워드] anti-SARS-CoV-2 antibody anti-SARS-CoV-2 IgG anti-SARS-CoV-2 IgG antibodies anti-SARS-CoV-2 IgG antibody antibody Antibody Response Antibody responses appearance classical Comorbidities concerning coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 infection Day demographics detect Efficacy first dose healthcare worker IgG antibodies IgG level IgG levels immunogenicity Immunosuppression inactive individuals infected with SARS-CoV-2 Infection information investigated majority Neutralizing activity positive postvaccination produced rapid increase SARS-CoV-2 screened second dose second vaccination seropositive seropositive individual seropositive individuals Seropositivity significantly higher Sinovac subject subjects Support Symptoms titers vaccination Vaccine virus [DOI] 10.1002/jmv.27649 PMC 바로가기 [Article Type] Article
Hospital-Wide SARS-CoV-2 seroprevalence in health care workers in a Spanish teaching hospital스페인 교육 병원에서 의료 종사자의 병원 전체 SARS-CoV-2 혈청 유병률Article Published on 2022-06-012022-09-12 Journal: Enfermedades infecciosas y microbiologia clinica ( [Category] COVID19(2023년), MERS, SARS, 진단, [키워드] age Analysis assistant Asymptomatic COVID-19 COVID-19 hospitalization Cross infection cross-sectional study Diseases ELISA Emergency English evaluated females HCW Health care worker Health personnel hospital Hospitalization identify IgG Infección nosocomial media medium multivariate logistic regression no difference Non-COVID-19 non-COVID-19 patient nosocomial Nurse PCR PCR-positive physician positive rate of infection risk room SARS-CoV-2 SARS-CoV-2 IgG SARS-CoV-2 seroprevalence SARS-CoV-2 transmission SARS-CoV2 Seroepidemiologic studies seropositive Seropositivity Seroprevalence Seroprevalencia Sex significantly Spanish Symptoms Trabajador sanitario. [DOI] 10.1016/j.eimce.2020.11.025 PMC 바로가기 [Article Type] Article
Seropositivity and neutralising antibodies at six months after BNT162b2 vaccination in patients with solid tumours고형암 환자에서 BNT162b2 접종 후 6개월째 혈청양성 및 중화항체Article Published on 2022-06-012022-09-12 Journal: European journal of cancer (Oxford, England : 1990 [Category] COVID19(2023년), MERS, SARS, 진단, [키워드] Analysis Antibody Response anticancer Blood BNT162b2 BNT162b2 vaccine Cancer collected comparable Control controls COVID-19 dose doses evaluated follow-up study health-care healthy controls IgG increased risk initial lymphocyte Lymphocyte count median neutralising antibody neutrophil count not correlated Patient Patients with cancer Predictive predictor Prospective Study RBD reported SARS-CoV-2 seropositive individuals Seropositivity severe coronavirus disease solid tumour the receptor-binding domain therapy titre titres Treatment vaccination vaccine dose were measured [DOI] 10.1016/j.ejca.2022.03.013 PMC 바로가기 [Article Type] Article
Risk Factors for SARS-CoV-2 Infection and Illness in Cats and Dogs 1고양이와 개의 SARS-CoV-2 감염 및 질병에 대한 위험 요소 1Article Published on 2022-06-012022-09-12 Journal: Emerging Infectious Diseases [Category] COVID19(2023년), MERS, SARS, 진단, [키워드] acute respiratory syndrome Canada clinics coronavirus coronavirus disease COVID-19 COVID-19 case dog ELISA et al. Risk factors for SARS-CoV-2 infection and illness in cats and dogs. Emerg Infect Dis. 2022 June [date cited]. https://doi.org/10.3201/eid2806.220423 Factor Human human-animal bond IgG and IgM IgM illness Infection Jacobson L likelihood MacNicol J Marom D PCR positive pets positive quantitative PCR respiratory respiratory infections risk factor Rousseau J SARS-CoV-2 SARS-CoV-2 IgG SARS-COV-2 infection seroconvert Seropositivity serum sample severe acute respiratory syndrome coronavirus 2 Sparling S Spike protein Suggested citation for this article: Bienzle D swab specimen tested viruses with COVID-19 zoonoses [DOI] 10.3201/eid2806.220423 PMC 바로가기 [Article Type] Article
A cross-section observational study on the seroprevalence of antibodies to COVID-19 in patients receiving opiate agonist treatment아편 제 작용제 치료를받는 환자에서 COVID-19에 대한 항체의 혈청 유병률에 대한 횡단면 관찰 연구Observational Study Published on 2022-06-012022-09-11 Journal: Irish Journal of Medical Science [Category] COVID19(2023년), MERS, SARS, 임상, 진단, 치료기술, [키워드] Administered antibody Buprenorphine Care care needs clinical symptom Cohort collected complex conducted COVID-19 COVID-19 in patient COVID-19 virus death detectable determine disease drug drug treatment explain exposure to Health majority measure medication Methadone OAT opiate Opiate substitution treatment OST pandemic Patient patient cohort patients positive result presence of antibody Protective protective effect provide Public public health measures questionnaire receiving reported Result SARS-CoV-2 Seropositivity Seroprevalence serum antibodies serum antibody Symptom tested the disease Treatment [DOI] 10.1007/s11845-021-02660-w PMC 바로가기 [Article Type] Observational Study
Prevalence of SARS-CoV-2 antibodies among nurses: A systematic review and meta-analysis간호사 중 SARS-CoV-2 항체 유병률: 체계적인 검토 및 메타 분석Meta-Analysis Published on 2022-06-012022-09-12 Journal: Journal of clinical nursing [Category] COVID19(2023년), MERS, SARS, 진단, [키워드] 95% CI African America Asia calculated Community community transmission comparable COVID-19 duplicate eligibility estimate European evaluated explain fear feature forest plot General population Health health system healthcare highest infection control item Joanna Briggs Institute majority Measures meta-analyses Meta-analysis Nurse Nurses outbreak pandemic participant Patient care Personal protective equipment positive serology PPE Prevalence random effect Region Relevance reported Reporting review risk SARS-CoV-2 SARS-CoV-2 antibody screened searched Seropositivity Seroprevalence similarities Social distancing measure stratified systematic review virus World Health Organisation [DOI] 10.1111/jocn.16009 PMC 바로가기 [Article Type] Meta-Analysis